Acquisitions – Page 2

Pfizer, Bristol Myers Squibb, and Johnson & Johnson: Navigating the Looming Patent Cliff

1 year ago talkbio0Tagged Acquisitions, Biological Factors, Biosimilars, Drug Industry, Johnson & Johnson, mergers, Myers, Patent Cliff, patent expirations, Pfizer, Revenue Loss, squibb

Patent Cliff, Pharmaceutical Industry, Pfizer, Bristol Myers Squibb, Johnson & Johnson, Patent Expirations, Biologics, Biosimilars, Revenue Loss, Mergers and Acquisitions

BMS Realigns Workforce Post-Mergers and Acquisitions: A Strategic Move Affecting 2,200 Employees

2 years ago talkbio0Tagged Acquisitions, Burning Mouth Syndrome, mergers, strategic, Workers

BMS, layoffs, mergers and acquisitions, workforce realignment, strategic move, 2, 200 employees

Novartis Appoints Ex-Bristol Myers CEO Giovanni Caforio as Chair: Potential for Future M&A Deals?

2 years ago talkbio0Tagged Acquisitions, Chairs, Corporate, Drug Industry, Giovanni Caforio, Leadership Change, M&A, mergers, Myers, Novartis

Novartis, Bristol Myers, Giovanni Caforio, Chair, Mergers and Acquisitions (M&A), Pharmaceutical Industry, Corporate Strategy, Leadership Change.